Pharmaceutical News

RSS

RNA interference agent plozasiran targets APOC3 for effective mixed hyperlipidemia treatment

Researchers evaluate the efficacy of plazosiran treatment on fasting triglyceride levels in adult patients with mixed hyperlipidemia.

31 May 2024

Study examines the cost-effectiveness of a targeted immunotherapy for lung cancer

Many countries with national healthcare systems or payers such as insurance companies use cost-effectiveness analyses to decide whether to cover new medicines, balancing treatment costs with potential health benefits.

30 May 2024

Study examines prescribing patterns of tricyclic antidepressants for treatment of diabetic peripheral neuropathy

Many adults with diabetes and the associated complication of peripheral neuropathy, which can be painful as well as harmful, are often prescribed drugs at doses and for durations that could impose an increased risk of cognitive impairment.

30 May 2024

Existing drug alleviates symptoms of a rare genetic syndrome

A drug approved to treat certain autoimmune diseases and cancers successfully alleviated symptoms of a rare genetic syndrome called autoimmune polyendocrine syndrome type 1 (APS-1).

30 May 2024

An obscure drug discount program stifles use of federal lifeline by rural hospitals

Facing ongoing concerns about rural hospital closures, Capitol Hill lawmakers have introduced a spate of proposals to fix a federal program created to keep lifesaving services in small towns nationwide.

30 May 2024

Could edible robots be the future of food and medicine?

A review in Nature Reviews Materials explores the potential of edible materials in creating robotic foods and edible robots, highlighting their therapeutic and environmental benefits, while addressing current research challenges.

29 May 2024

Oral semaglutide shows significant promise in improving diabetes control and cardiovascular health, study reveals

A recent study in the Journal of Clinical Medicine found that oral semaglutide significantly improves glycemic control and reduces body weight in type 2 diabetes patients after 24 weeks of treatment.

29 May 2024

New antibiotic lolamicin shows promise in fighting drug-resistant infections

Researchers have developed a new antibiotic that reduced or eliminated drug-resistant bacterial infections in mouse models of acute pneumonia and sepsis while sparing healthy microbes in the mouse gut.

29 May 2024

Psychoactive drugs are having a moment. The FDA will soon weigh in.

Lori Tipton is among the growing number of people who say that MDMA, also known as ecstasy, saved their lives.

29 May 2024

Secarna Pharmaceuticals and Orbit Discovery enter collaboration to discover and develop peptide-conjugated targeted antisense oligonucleotide therapeutics

Secarna Pharmaceuticals GmbH & Co. KG (Secarna), a leading independent European antisense drug discovery and development company, and Orbit Discovery Ltd. (Orbit), a leader in the discovery of therapeutic peptide hits, today announced that they have entered into a collaboration to discover and develop peptide-conjugated targeted antisense oligonucleotide (ASO) therapeutics.

From Secarna Pharmaceuticals 29 May 2024

New Alzheimer's drug LM11A-31 shows promise in slowing disease progression in clinical trial

A recent study in Nature Medicine found that LM11A-31, targeting the p75 neurotrophin receptor, is safe and shows promise in slowing Alzheimer's disease progression. The trial indicated significant biomarker improvements and potential benefits for further clinical investigation.

28 May 2024

Semaglutide shows significant kidney benefits in non-diabetic obese patients with heart disease

A recent study in Nature Medicine shows semaglutide reduces kidney risks in non-diabetic obese patients with cardiovascular disease by 22%. The SELECT trial results highlight semaglutide's benefits for kidney function and overall cardiovascular health.

28 May 2024

Silibinin: An old molecule with new promise in cancer treatment

1
2
3
4
...
1416
Next

Pharmaceutical News

RNA interference agent plozasiran targets APOC3 for effective mixed hyperlipidemia treatment

Study examines the cost-effectiveness of a targeted immunotherapy for lung cancer

Study examines prescribing patterns of tricyclic antidepressants for treatment of diabetic peripheral neuropathy

Existing drug alleviates symptoms of a rare genetic syndrome

An obscure drug discount program stifles use of federal lifeline by rural hospitals

Could edible robots be the future of food and medicine?

Oral semaglutide shows significant promise in improving diabetes control and cardiovascular health, study reveals

New antibiotic lolamicin shows promise in fighting drug-resistant infections

Psychoactive drugs are having a moment. The FDA will soon weigh in.

Secarna Pharmaceuticals and Orbit Discovery enter collaboration to discover and develop peptide-conjugated targeted antisense oligonucleotide therapeutics

New Alzheimer's drug LM11A-31 shows promise in slowing disease progression in clinical trial

Semaglutide shows significant kidney benefits in non-diabetic obese patients with heart disease

Silibinin: An old molecule with new promise in cancer treatment

Novel coating in antipsychotics mitigates unwanted weight gain and boosts serotonin levels

Taking semaglutide once weekly may lower the chances of kidney disease, says study

Increased risk of erectile dysfunction with semaglutide in non-diabetic obese patients

New understanding of cancer drug's ability to prevent fat buildup in the liver

Tailoring polymeric micelles for improved olaparib solubility and drug release

Clomiphene and dexamethasone boost fertility in PCOS patients

Dupilumab shows promise in cutting COPD flare-ups and boosting lung function

Discover how SciY empowers scientists

Why use light scattering to analyze proteins and viral vectors?

Changing the landscape of R&D to build clinical success from the ground up

Latest News